Position in ELAN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$872,368
+$653,401 QoQ
Shares Held
36,455
+276.8% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Crossmark Global Holdings, Inc. holds $36,724,175 across 14 Drug Manufacturers - Specialty & Generic names. ELAN ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
777,148 | $14,392,780 | |
| 2 | HLN |
Haleon plc
|
749,365 | $7,501,143 | |
| 3 | ZTS |
Zoetis Inc.
|
63,064 | $7,454,795 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
3,064 | $1,816,890 | |
| 5 | HCM |
HUTCHMED (China) Ltd
|
84,963 | $1,271,046 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
8,467 | $1,115,442 | |
| 7 | ELAN |
Elanco Animal Health Inc
This page
|
36,455 | $872,368 | |
| 8 | VTRS |
Viatris Inc
|
37,258 | $503,355 |
All Filings in ELAN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $872,368 | 36,455 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $218,967 | 9,676 | Shares | Sole | 2026-02-03 | |
| No filing history on record for this holder in this stock. | ||||||